Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Better Therapeutics Inc (BTTX)

Better Therapeutics Inc (BTTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Better Therapeutics Inc 548 MARKET ST. #49404 SAN FRANCISCO CA 94104 USA

www.bettertx.com P: 415-887-2311

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Better Therapeutics Inc. is a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases. Better Therapeutics Inc., formerly known as Mountain Crest Acquisition Corp II, is based in SAN FRANCISCO.

Key Statistics

Overview:

Market Capitalization, $K 4
Enterprise Value, $K -856
Shares Outstanding, K 40,580
Float, K 11,591
% Float 48.60%
Short Interest, K 1
Short Float 0.00%
Days to Cover 23.00
Short Volume Ratio 1.00
% of Insider Shareholders 51.40%
% of Institutional Shareholders 34.00%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -39,760 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,860 K
EBIT, $ -29,620 K
EBITDA, $ -26,890 K

Growth:

1-Year Return 0.00%
3-Year Return -99.99%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 01/02/25
Earnings Per Share ttm -1.15
EPS Growth vs. Prev Year -43.07%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

BTTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity -1.44
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.24
Interest Coverage -25.68
60-Month Beta 0.98
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar